BeyondSpring's IPO

BeyondSpring raised a round of funding on March 09, 2017. Investors include Public.

BeyondSpring Pharmaceuticals (NASDAQ: BYSI) is a global, clinical-stage biopharmaceutical company focused on the development of cancer therapies.…

Articles about BeyondSpring's IPO: